Source:http://linkedlifedata.com/resource/pubmed/id/20071790
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2010-1-14
|
| pubmed:abstractText |
Ephrin A4 is one of the ephrin ligand molecules belonging to the tyrosine kinases receptor family. It was originally identified in a T-lymphoma cell line and seen to be expressed in human adult tissue as well as several tumor types. In our previous study, we showed the unique pattern of ephrin A4 immunohistochemical staining, which differed according to the type of examined bone specimens (normal bone, primary, and metastatic osteosarcoma lesions). The aim of the present study is to evaluate the prognostic impact of ephrin A4 expression in a group of primary osteosarcoma patients.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1998-4774
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
47
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
46-52
|
| pubmed:meshHeading |
pubmed-meshheading:20071790-Antineoplastic Agents,
pubmed-meshheading:20071790-Bone Neoplasms,
pubmed-meshheading:20071790-Ephrin-A4,
pubmed-meshheading:20071790-Humans,
pubmed-meshheading:20071790-Immunohistochemistry,
pubmed-meshheading:20071790-Neoplasm Staging,
pubmed-meshheading:20071790-Osteosarcoma,
pubmed-meshheading:20071790-Prognosis,
pubmed-meshheading:20071790-Proportional Hazards Models,
pubmed-meshheading:20071790-Treatment Outcome,
pubmed-meshheading:20071790-Tumor Markers, Biological
|
| pubmed:articleTitle |
Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome.
|
| pubmed:affiliation |
Department of Pathology, Faculty of Medicine, Menofiya University, Shebein Elkom, Egypt.
|
| pubmed:publicationType |
Journal Article
|